Preparation of a purified, inactivated Japanese encephalitis (JE) virus vaccine in Vero cells

Biotechnology Letters

Volumn 23, Issue 19, 2001, Pages 1565-1573

  Pyo Hong, Sun ^a,c   Yoo, Wang Don ^a   Putnak, Robert ^b   Srivastava, Ashok K ^b   Eckels, Kenneth H ^b   Chung, Yong Ju ^a   Mo Rho, Hyune ^a   Kim, Soo Ok ^a  

^a CJ Corporation   (South Korea)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Seoul National University   (South Korea)

Author keywords

Japanese encephalitis; Vaccine; Vero cells

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ANIMAL CELL; ANTIGENICITY; ARTICLE; DENSITY GRADIENT CENTRIFUGATION; DRUG SYNTHESIS; JAPANESE ENCEPHALITIS VIRUS; MONKEY; NONHUMAN; ULTRAFILTRATION; VERO CELL; VIROGENESIS; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS PURIFICATION;

EID: 0034788258     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011917326672     Document Type: Article

References (26)

1. Side effects with Japanese encephalitis vaccine
2. Examination of the glycoprotein of yellow fever vaccine viruses with monoclonal antibodies
3. Japanese encephalitis
4. 'Western blotting': Electrophoretic transfer of proteins from sodium dodecyl sulphate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radiolabelled protein A
5. Rabies vaccine for human use, cultivated on Vero cells
6. Isolation of a temperature-sensitive dengue-2 virus under condition suitable for vaccine development
7. 14-A14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use
8. Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice
9. Protection against Japanese encephalitis by inactivated vaccines
10. Studies on the antigenic structure of Japanese encephalitis virus using monoclonal antibodies
11. Rabies risk and immunoprophylaxis in children
12. Flavivirus
13. Polio and rabies vaccines produced in continuous cell lines: A reality for Vero cell line
14. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA 14
15. Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)
16. An epidemiological review of Japanese encephalitis
17. Japanese encephalitis vaccine
18. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in U.S. habitants
19. A simple method of estimating fifty percent endpoints
20. Further experience with Japanese encephalitis vaccine
21. Antigenicity of Japanese encephalitis virus envelope protein V3(E) and its cyanogens bromide cleaved fragments examined by monoclonal antibodies and Western blotting
22. Japanese encephalitis: A Chinese solution?
23. Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA
24. New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting
25. Japanese encephalitis vaccine
26. Japanese encephalitis: Current worldwide status